Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2012-12-01 02:04 2012-11-28 ATEC Alphatec Holdings, Inc. HGP LLC 10% owner SELL $1.51 100,000 $151,000 10,777,173
2012-12-01 02:01 2012-11-28 ATEC Alphatec Holdings, Inc. Berkowitz Mortimer III Director, 10% owner SELL $1.51 200,000 $302,000 21,010,565
2012-12-01 01:57 2012-11-28 ATEC Alphatec Holdings, Inc. Foster John Director, 10% owner SELL $1.51 200,000 $302,000 21,010,565
2012-11-30 16:54 2012-11-28 SYK STRYKER CORP STRYKER RONDA E Director SELL $54.42 18,000 $979,564 12,778,682
2012-12-01 01:44 2012-11-28 LMAT LEMAITRE VASCULAR INC LeMaitre Cornelia W Director, Officer SELL $6.25 1,000 $6,250 242,934
2012-11-29 19:49 2012-11-27 SNWV SANUWAVE Health, Inc. Nemelka David Nephi Jr. 10% owner BUY $0.25 4,000,000 $1,000,000 4,839,259
2012-11-30 03:13 2012-11-26 ATEC Alphatec Holdings, Inc. CROSS LESLIE H Director, Officer BUY $1.57 20,000 $31,400 364,146
2012-11-30 03:10 2012-11-27 UTMD UTAH MEDICAL PRODUCTS INC HOYER ERNST G Director SELL $35.21 500 $17,607 51,343
2012-11-29 01:24 2012-11-26 ATRC AtriCure, Inc. Discovery Group I, LLC 10% owner SELL $7.14 7,445 $53,122 1,792,095
2012-11-28 17:30 2012-11-26 ATEC Alphatec Holdings, Inc. CROSS LESLIE H Director, Officer BUY $1.56 20,000 $31,200 344,146
2012-11-28 01:03 2012-11-23 UFPT UFP TECHNOLOGIES INC Stevenson David K Director SELL $16.07 1 $16 20,246
2012-11-28 04:40 2012-11-23 SYK STRYKER CORP STRYKER RONDA E Director SELL $54.18 27,000 $1,462,752 12,796,682
2012-11-28 02:16 2012-11-23 LMAT LEMAITRE VASCULAR INC LeMaitre Cornelia W Director, Officer SELL $6.25 2,699 $16,869 243,934
2012-11-26 20:22 2012-11-21 ATEC Alphatec Holdings, Inc. CROSS LESLIE H Director, Officer BUY $1.55 10,000 $15,500 324,146
2012-11-27 00:48 2012-11-21 UFPT UFP TECHNOLOGIES INC GESTAL KENNETH L Director SELL $15.91 2,446 $38,923 40,623
2012-11-27 03:48 2012-11-21 UTMD UTAH MEDICAL PRODUCTS INC HOYER ERNST G Director SELL $35.19 1,901 $66,889 51,843
2012-11-27 04:24 2012-11-21 ARAY Accuray Incorporated GOLDSTEIN JACK Director SELL $6.37 11,900 $75,824 39,092
2012-11-26 22:23 2012-11-21 BDX BECTON DICKINSON & CO BECTON HENRY P JR Director OPT+S $76.27 2,781 $212,107 94,446
2012-11-23 20:52 2012-11-20 ATRC AtriCure, Inc. Discovery Group I, LLC 10% owner SELL $7.22 2,093 $15,105 1,799,540
2012-11-23 14:18 2012-11-21 NSPR-OB InspireMD, Inc. BARER SOL J Director BUY $1.33 34,980 $46,516 4,000,000
2012-11-23 14:10 2012-11-20 LMAT LEMAITRE VASCULAR INC LeMaitre Cornelia W Director, Officer SELL $6.25 6,301 $39,381 246,633
2012-11-24 03:12 2012-11-20 OSUR ORASURE TECHNOLOGIES INC WATSON DOUGLAS G Director OPT+S $7.55 60,000 $452,760 98,281
2012-11-22 03:30 2012-11-20 RMD RESMED INC Darkin Donald Officer OPT+S $40.05 30,000 $1,201,410 20,000
2012-11-22 01:13 2012-11-19 PDEX PRO DEX INC Swenson Nicholas John 10% owner BUY $1.97 9,884 $19,436 102,264
2012-11-22 03:29 2012-11-19 RMD RESMED INC Sandercock Brett Officer SELL $40.66 30,000 $1,219,740 68,684
2012-11-21 21:13 2012-11-20 HAE HAEMONETICS CORP LINDOP CHRISTOPHER J Officer SELL $80.95 278 $22,504 15,198
2012-11-21 21:12 2012-11-19 HAE HAEMONETICS CORP KROLL MARK W Director OPT+S $80.13 4,592 $367,957 4,176
2012-11-21 21:13 2012-11-19 HAE HAEMONETICS CORP MERRIMAN RONALD Director SELL $80.98 1,008 $81,628 5,168
2012-11-21 20:18 2012-11-20 NSPR-OB InspireMD, Inc. BARER SOL J Director BUY $1.29 15,020 $19,449 3,965,020
2012-11-21 21:45 2012-11-21 SYK STRYKER CORP STRYKER RONDA E Director SELL $53.49 9,000 $481,429 12,823,682
2012-11-21 00:44 2012-11-16 UFPT UFP TECHNOLOGIES INC Pierce Robert W Jr Director BUY $15.72 201 $3,160 18,551
2012-11-20 18:59 2012-11-16 HAE HAEMONETICS CORP KROLL MARK W Director OPT+S $79.67 6,000 $478,033 4,176
2012-11-20 14:02 2012-11-19 NSPR-OB InspireMD, Inc. BARER SOL J Director BUY $1.38 14,441 $19,992 3,950,000
2012-11-20 23:38 2012-11-16 SYK STRYKER CORP STRYKER RONDA E Director SELL $52.74 27,000 $1,424,026 12,832,682
2012-11-21 00:47 2012-11-20 UFPT UFP TECHNOLOGIES INC GESTAL KENNETH L Director SELL $16.00 293 $4,688 43,069
2012-11-21 03:35 2012-11-20 UTMD UTAH MEDICAL PRODUCTS INC HOYER ERNST G Director SELL $34.95 100 $3,495 53,744
2012-11-21 04:18 2012-11-19 CERS CERUS CORP Greenman William Mariner Director, Officer BUY $3.02 3,200 $9,664 128,681
2012-11-19 14:04 2012-11-16 NSPR-OB InspireMD, Inc. BARER SOL J Director BUY $1.27 35,559 $45,103 3,935,559
2012-11-20 04:03 2012-11-15 RMD RESMED INC PENDARVIS DAVID Officer SELL $38.96 85,302 $3,323,315 59,274
2012-11-17 04:50 2012-11-16 CERS CERUS CORP Greenman William Mariner Director, Officer BUY $2.85 13,800 $39,388 125,481
2012-11-17 01:41 2012-11-16 CERS CERUS CORP CORASH LAURENCE M Director, Officer BUY $2.85 2,000 $5,698 574,200
2012-11-16 05:19 2012-11-13 RMD RESMED INC Darkin Donald Officer OPT+S $39.31 24,210 $951,794 20,000
2012-11-15 21:44 2012-11-14 SYK STRYKER CORP STRYKER RONDA E Director SELL $52.30 18,000 $941,400 12,859,682
2012-11-16 00:58 2012-11-13 BSX BOSTON SCIENTIFIC CORP NICHOLAS NJ JR Director BUY $5.28 20,000 $105,596 225,000
2012-11-16 01:44 2012-11-14 CRY Artivion Inc. McCall Ronald D Director SELL $5.72 6,000 $34,322 137,162
2012-11-15 01:35 2012-11-12 HAE HAEMONETICS CORP GRANADILLO PEDRO P Director OPT+S $80.40 16,000 $1,286,341 6,626
2012-11-14 00:56 2012-11-12 UFPT UFP TECHNOLOGIES INC Stevenson David K Director SELL $15.73 1,347 $21,190 20,247
2012-11-13 18:08 2012-11-05 ANGO Angiodynamics Inc. GOLD JEFFREY Director BUY $10.56 1,000 $10,560 25,233
2012-11-13 21:17 2012-11-09 SYK STRYKER CORP STRYKER RONDA E Director SELL $52.67 27,000 $1,422,106 12,877,682
2012-11-13 14:05 2012-11-09 BSX BOSTON SCIENTIFIC CORP NICHOLAS NJ JR Director BUY $5.17 25,000 $129,305 205,000
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.